CDS revised downward its consolidated earnings forecast for the cumulative second quarter of the fiscal year ending December 2026.
資産への影響 6
Stemrim reported that a patent for its regenerative medicine Redasemtide related to cartilage disease has been registered in Mexico.
Tsubota Laboratory achieved a milestone upon submission of the clinical study report for TLG-001, confirming receipt of payment.
OBC reported a sharp profit increase for the first quarter of the fiscal year ending March 2027.
Bronco Billy announced its financial results and revised earnings and dividend forecasts, but the article does not specify the direction of the revision.
AZC Maruwa introduced a new shareholder benefit program, which is a capital event but impact is unclear.